LAM
NVO

LOM Asset Management’s Novo Nordisk NVO Stock Holding History

LOM Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$753K Sell
15,713
-637
-4% -$27.4K 0.19% 108
2026
Q1 		$601K Sell
16,350
-100
-0.6% -$4.74K 0.17% 119
2025
Q4 		$837K Sell
16,450
-40
-0.2% -$2.04K 0.24% 105
2025
Q3 		$915K Buy
16,490
+15,425
+1,448% +$903K 0.28% 100
2025
Q2 		$74K Buy
+1,065
New +$72.4K 0.03% 170

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LOM Asset Management's NVO Position: Q2 2026 in Review

LOM Asset Management reduced its Novo Nordisk (NVO) stake by 3.9% in Q2 2026, selling an estimated $27.4K and leaving 15,713 shares worth $753K. The position accounts for 0.19% of the portfolio, ranked #108.

LOM Asset Management first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $915K in Q3 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • LOM Asset Management held 15,713 shares of Novo Nordisk worth $753K as of Q2 2026.
  • LOM Asset Management sold 637 Novo Nordisk shares in Q2 2026, an estimated $27.4K.
  • Novo Nordisk made up 0.19% of LOM Asset Management's portfolio in Q2 2026, its #108 holding.
  • LOM Asset Management first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • LOM Asset Management's Novo Nordisk position peaked at $915K in Q3 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on LOM Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.